For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...

Glucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and which helps regulate blood sugar ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

(HealthDay News) — A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have a ...

Data suggests that some sectors of Europe's confectionery sector are declining. Could GLP-1s have a role to play in this?

A UK government and Eli Lilly £85 million program will expand obesity care nationwide, offering digital, community, and ...

"Tirzepatide and other drugs like it, such as semaglutide, will help people living with obesity to lose weight, and as a ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.